Shanghai Xuerong Bio-Technology Co Ltd (SHE:300511) — Stock Price
Shanghai Xuerong Bio-Technology Co Ltd (SHE:300511) is currently trading at CN¥5.49 CNY, up 4.17% today. Over the past 52 weeks, shares have ranged between CN¥4.77 and CN¥8.24. This page tracks Shanghai Xuerong Bio-Technology Co Ltd's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Shanghai Xuerong Bio-Technology Co Ltd worth.
Shanghai Xuerong Bio-Technology Co Ltd (300511) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Shanghai Xuerong Bio-Technology Co Ltd's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Shanghai Xuerong Bio-Technology Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Shanghai Xuerong Bio-Technology Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CN¥2.16 Billion | CN¥2.57 Billion | CN¥2.32 Billion | CN¥2.06 Billion | CN¥2.20 Billion |
| Cost of Revenue | CN¥2.08 Billion | CN¥2.35 Billion | CN¥2.07 Billion | CN¥1.95 Billion | CN¥1.72 Billion |
| Gross Profit | CN¥77.95 Million | CN¥215.07 Million | CN¥248.39 Million | CN¥108.57 Million | CN¥480.97 Million |
| Research & Development | CN¥3.46 Million | CN¥6.84 Million | CN¥7.49 Million | CN¥13.56 Million | CN¥11.85 Million |
| SG&A | CN¥37.23 Million | CN¥65.79 Million | CN¥23.75 Million | CN¥72.01 Million | CN¥84.13 Million |
| Total Operating Expenses | CN¥2.26 Billion | CN¥2.61 Billion | CN¥2.22 Billion | CN¥2.13 Billion | CN¥1.90 Billion |
| Operating Income | CN¥-99.89 Million | CN¥-41.80 Million | CN¥100.47 Million | CN¥-64.18 Million | CN¥306.20 Million |
| EBITDA | — | — | CN¥53.75 Million | CN¥38.41 Million | CN¥615.79 Million |
| EBIT | — | — | — | CN¥-131.45 Million | CN¥266.23 Million |
| Interest Expense | CN¥98.21 Million | CN¥88.77 Million | CN¥92.96 Million | CN¥77.11 Million | CN¥71.66 Million |
| Income Before Tax | CN¥-616.41 Million | CN¥-192.10 Million | CN¥-380.55 Million | CN¥-352.96 Million | CN¥221.81 Million |
| Income Tax Expense | — | — | — | CN¥-4.49 Million | CN¥-3.24 Million |
| Net Income | CN¥-617.07 Million | CN¥-188.06 Million | CN¥-287.23 Million | CN¥-308.90 Million | CN¥247.24 Million |
Shanghai Xuerong Bio-Technology Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Shanghai Xuerong Bio-Technology Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CN¥3.85 Billion | CN¥4.60 Billion | CN¥4.07 Billion | CN¥4.34 Billion | CN¥4.56 Billion |
| Total Current Assets | CN¥546.31 Million | CN¥766.60 Million | CN¥1.19 Billion | CN¥874.94 Million | CN¥1.23 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | CN¥270.00 Million | — | — |
| Net Receivables | CN¥31.39 Million | CN¥33.48 Million | CN¥29.02 Million | CN¥47.74 Million | CN¥23.79 Million |
| Inventory | CN¥325.34 Million | CN¥442.86 Million | CN¥443.28 Million | CN¥384.08 Million | CN¥382.65 Million |
| Property, Plant & Equipment | — | — | — | CN¥2.95 Billion | CN¥2.80 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥3.03 Billion | CN¥3.17 Billion | CN¥2.45 Billion | CN¥2.69 Billion | CN¥2.54 Billion |
| Total Current Liabilities | CN¥1.95 Billion | CN¥2.11 Billion | CN¥1.30 Billion | CN¥1.61 Billion | CN¥1.39 Billion |
| Long-term Debt | CN¥960.21 Million | CN¥948.27 Million | CN¥973.69 Million | CN¥938.01 Million | CN¥1.03 Billion |
| Net Debt | CN¥1.76 Billion | CN¥1.73 Billion | CN¥1.19 Billion | CN¥1.37 Billion | CN¥924.28 Million |
| Total Stockholder Equity | CN¥938.63 Million | CN¥1.55 Billion | CN¥1.74 Billion | CN¥1.67 Billion | CN¥2.03 Billion |
| Retained Earnings | CN¥-464.75 Million | CN¥152.87 Million | CN¥342.40 Million | CN¥727.07 Million | CN¥1.09 Billion |
Shanghai Xuerong Bio-Technology Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Shanghai Xuerong Bio-Technology Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥437.20 Million | CN¥357.84 Million | CN¥367.13 Million | CN¥246.75 Million | CN¥555.47 Million |
| Capital Expenditures | CN¥327.46 Million | CN¥1.10 Billion | CN¥319.47 Million | CN¥639.87 Million | CN¥482.79 Million |
| Free Cash Flow | CN¥109.74 Million | CN¥-739.19 Million | CN¥47.66 Million | CN¥-393.13 Million | CN¥72.68 Million |
| Investing Cash Flow | — | — | — | CN¥-597.38 Million | CN¥-523.58 Million |
| Financing Cash Flow | — | — | — | CN¥-68.50 Million | CN¥461.90 Million |
| Dividends Paid | CN¥-67.01 Million | CN¥-60.32 Million | CN¥58.73 Million | CN¥102.59 Million | CN¥115.86 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥373.92 Million | CN¥324.76 Million | CN¥341.34 Million | CN¥313.70 Million | CN¥322.32 Million |
| Change in Cash | CN¥-8.02 Million | CN¥-192.60 Million | CN¥11.18 Million | CN¥-420.49 Million | CN¥492.17 Million |
Shanghai Xuerong Bio-Technology Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Shanghai Xuerong Bio-Technology Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Sep 30, 2025 | 0.06 | — | — |
| Jun 30, 2025 | -0.18 | — | — |
| Apr 27, 2025 | 0.01 | — | — |
| Dec 31, 2024 | -0.91 | — | — |
| Oct 24, 2024 | -0.04 | — | — |
| Aug 28, 2024 | -0.30 | — | — |
| Apr 25, 2024 | 0.01 | — | — |
| Mar 28, 2024 | -0.12 | — | — |